A phase II study of irinotecan as a third- or fourth-line...

Respiratory Investigation 2013 / 03 Vol. 51; Iss. 1

A phase II study of irinotecan as a third- or fourth-line treatment for advanced non-small cell lung cancer: NJLCG0703

Matsubara, Nobumichi, Maemondo, Makoto, Inoue, Akira, Ishimoto, Osamu, Watanabe, Kana, Sakakibara, Tomohiro, Fukuhara, Tatsuro, Morikawa, Naoto, Tanaka, Masashi, Sugawara, Shunichi, Nukiwa, Toshihiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
51
Language:
english
Journal:
Respiratory Investigation
DOI:
10.1016/j.resinv.2012.09.004
Date:
March, 2013
File:
PDF, 321 KB
english, 2013
Conversion to is in progress
Conversion to is failed